Evidence map›Paper›PMID 28077935›Full record

ArticleClinical proteomics2017

Development of a microarray-based method for allergen-specific IgE and IgG4 detection.

Guzel Feyzkhanova, Sergei Voloshin, Olga Smoldovskaya, Alla Arefieva, Marina Filippova, Viktor Barsky, Ludmila Pavlushkina, Veronika Butvilovskaya, Alexei Tikhonov, Yuri Reznikov and 1 more

Open access · goldAbstract read
In one paragraph

Article in Clinical proteomics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Well-Based Multiplex Food Allergen Colorimetric ELISA.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Guzel FeyzkhanovaEngelhardt Institute of Molecular Biology, Russian Academy of Sciences (EIMB RAS), Vavilova str., 32, Moscow, Russia 119991.
Sergei VoloshinEngelhardt Institute of Molecular Biology, Russian Academy of Sciences (EIMB RAS), Vavilova str., 32, Moscow, Russia 119991.
Olga SmoldovskayaEngelhardt Institute of Molecular Biology, Russian Academy of Sciences (EIMB RAS), Vavilova str., 32, Moscow, Russia 119991.
Alla ArefievaEngelhardt Institute of Molecular Biology, Russian Academy of Sciences (EIMB RAS), Vavilova str., 32, Moscow, Russia 119991.
Marina FilippovaEngelhardt Institute of Molecular Biology, Russian Academy of Sciences (EIMB RAS), Vavilova str., 32, Moscow, Russia 119991.
Viktor BarskyEngelhardt Institute of Molecular Biology, Russian Academy of Sciences (EIMB RAS), Vavilova str., 32, Moscow, Russia 119991.
Ludmila PavlushkinaEngelhardt Institute of Molecular Biology, Russian Academy of Sciences (EIMB RAS), Vavilova str., 32, Moscow, Russia 119991.
Veronika ButvilovskayaEngelhardt Institute of Molecular Biology, Russian Academy of Sciences (EIMB RAS), Vavilova str., 32, Moscow, Russia 119991.
Alexei TikhonovEngelhardt Institute of Molecular Biology, Russian Academy of Sciences (EIMB RAS), Vavilova str., 32, Moscow, Russia 119991.
Yuri ReznikovEngelhardt Institute of Molecular Biology, Russian Academy of Sciences (EIMB RAS), Vavilova str., 32, Moscow, Russia 119991.
Alla RubinaEngelhardt Institute of Molecular Biology, Russian Academy of Sciences (EIMB RAS), Vavilova str., 32, Moscow, Russia 119991.
Engelhardt Institute of Molecular Biology · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundsIgE and sIgG4 detection is necessary for more accurate and effective type I hypersensitivity diagnostics and the estimation of disease development. Typically, the analyses of these antibodies are performed separately with the help of various specialized systems. The aim of this study was to develop a microarray-based method for the simultaneous quantitative detection of sIgE and sIgG4 to the most common allergens in a single sample.

methodsA quantitative method for the simultaneous detection of sIgE and sIgG4 was developed based on the technology of hydrogel microchips previously designed at Engelhardt Institute of Molecular Biology, Russian Academy of Sciences (EIMB RAS). The microarray contained gel pads with immobilized allergens and gel pads that allow for the obtaining of sIgE and sIgG4 internal calibration curves for each allergen during the assay. The possibility of the simultaneous detection of sIgE and sIgG4 was developed using the corresponding Cy5 and Cy3 fluorescent dyes.

resultsThe multiplex immunoassay method using hydrogel microarrays developed in this study allowed the quantitative detection of sIgE and sIgG4 to 31 allergens from different groups in a single assay. A comparison of the microarray with the existing plate-based analogues (i.e., ALLERG-O-LIQ and sIgG4 ELISA) was performed by analysing 152 blood serum samples and by evaluating Pearson correlation coefficients, ROC analysis, and Passing-Bablok linear regression results.

conclusionThe implementation of this method in allergy diagnostics will provide the possibility of simultaneously performing primary patient screening and obtaining additional information concerning the severity of the allergies and the choice of an appropriate therapy.

Indexed as

Allergy diagnosticsBiochipsImmunoassayMicroarrayssIgG4

Identifiers

PMID28077935
PMCPMC5223422
OpenAlexW2569551111

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.